Shares of CombiMatrix, Helicos Hit Hard in Tough May for Stock Market | GenomeWeb

This is a corrected version of an article that appeared briefly on the GenomeWeb site earlier Wednesday that contained incorrect historical stock data.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of CombiMatrix and Helicos BioSciences dropped sharply during the month of May, as the broader market sagged and both firms recently announced restructurings and reported declines in first-quarter revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.